In Depth 18 Feb 2025 T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments T cell engagers represent a novel approach to tuning the immune system to target and kill tumor cells, expanding treatment options for cancer. The first T cell engager drug earned… February 18, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 3 May 2023 Immunotherapy in the fight against solid tumors …target antigens in solid tumors resulting in ‘on-target, off-tumor toxicity’ where the healthy tissue is damaged, and the immunosuppressive tumor microenvironment that tends to shut T cells down,” said Sheppard. … May 3, 2023 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 4 May 2023 Five advancements in lupus research over the past year …by affecting T cell function, you want to inhibit inflammatory T cells but not harm regulatory T cells. That’s exactly what targeting the transferrin receptor did,” said Voss. With this… May 4, 2023 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 18 Jun 2025 10 cultured meat companies driving sustainable food in 2025 …conclusion that its chicken is safe to eat. The company then went on to become the join-first, alongside Good Meat, to have its cultured chicken approved by the USDA in… June 18, 2025 - 14 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 8 Apr 2025 13 anti-aging startups on a mission to extend lives …identify specific druggable targets before developing them into therapeutics that selectively target the pathologic cells that drive the aging process. The platform allows the company to develop novel small molecules… April 8, 2025 - 19 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 31 Oct 2024 Five T cell engager companies you should know about …a cancer cell and trigger a molecule on T cells. These therapeutic molecules then engage T cells that are present in tumors but that are not capable of recognizing cancer… October 31, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 19 Sep 2018 Using Stem Cells to Save the Northern White Rhino …sad truth is that many more species will share this dark prospect with the two rhinos. With largely human-made threats ranging from excessive poaching, loss of habitat, climate change and… September 19, 2018 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 22 May 2023 Cancer implications as new molecule can kill ‘zombie’ cells …with the University of Leicester in the U.K. have discovered a new molecule that is able to destroy these old cells without affecting healthy ones. This paves the way to… May 22, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 30 Apr 2025 The future of NSCLC treatment: what’s in store for the therapeutic space? …to potentially address NSCLC, particularly late-stage cancer that is often difficult to treat. Table of contents NSCLC treatments: current state of the field The most common form of lung cancer,… April 30, 2025 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Mar 2024 Are these T cell receptor (TCR) therapy companies on your radar? …those T cells that identify healthy cells are removed during thymic selection, to specifically target only diseased cells. Adaptimmune’s SPEAR T cells use the patient’s own T cells, which are… March 28, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 27 Feb 2024 Japan’s ten hottest biotech companies in healthcare …This company is developing CAR-T cell therapies for the treatment of cancer, which traditionally consist of extracting the patient’s immune T cells, engineering them in the lab to hunt down… February 27, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 7 May 2025 Unlocking immunity: the power of TLR agonists …and recruit immune cells against cancer cells. The drug also incites the death of these target cells. Two other TLR agonist therapies that have been cleared by the FDA are… May 7, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email